UnitedHealth Group reported FY2025 adjusted EPS of $16.35, slightly ahead of expectations, on revenue of $448 billion (12% growth). Results included a $1.6 billion net charge related to Optum restructuring and cyber remediation. For 2026, the company projects adjusted EPS greater than $17.75 (growth of at least 8.6%) on revenue of approximately $440 billion. The primary strategic shift is a move from volume to value, with UnitedHealthcare intentionally shedding 2.3 to 2.8 million members (including 1.3-1.4 million Medicare Advantage lives) to drive margin recovery of approximately 40 basis points. Optum is undergoing a 'back to basics' restructuring, particularly within OptumHealth, to stabilize operations and return to consistent growth. Management remains confident in long-term growth potential, citing AI investments ($1.5 billion planned for 2026) and a renewed focus on value-based care.
| Metric | Value | Change |
|---|---|---|
| FY2025 Adjusted EPS | $16.35 | Slightly ahead of expectations |
| FY2025 Revenue | $448 Billion | +12% |
| FY2025 Medical Care Ratio | 89.1% | Slightly better than expected |
| 2026 Adjusted EPS Guidance | >$17.75 | Growth of at least 8.6% |
| 2026 Revenue Guidance | ~$440 Billion | Decline from 2025 |
| 2026 Medical Care Ratio Guidance | 88.8% | Improvement of ~30 bps |
| Expected MA Membership Change (2026) | -1.3 to -1.4 Million | Contraction |
| Expected Total Membership Change (2026) | -2.3 to -2.8 Million | Contraction |
UnitedHealthcare is executing a decisive pivot to profitability over volume. By repricing insurance products and rightsizing membership, UHC expects to shed 1.3 to 1.4 million Medicare Advantage members and 500,000+ ACA members. This 'intentional' contraction is designed to restore margins by 40 basis points in 2026, signaling a refusal to underwrite unprofitable business regardless of market share implications.
OptumHealth is undergoing a fundamental restructuring to return to its 'original purpose' of integrated value-based care. The segment narrowed its affiliated network by 20% and streamlined risk membership by 15% to eliminate unaligned contracts. While this caused Q4 volatility and missed earnings targets, management believes this 'back to basics' focus creates a stronger baseline for future growth and margin expansion.
The company is leveraging Artificial Intelligence as a core operational lever, planning to invest $1.5 billion in 2026. This investment is expected to drive $1 billion in operating cost reductions and enhance customer service, with over 80% of member calls already utilizing AI tools. This signals a shift towards using technology to offset medical cost inflation and administrative bloat.
OptumRx is successfully diversifying its book of business beyond internal UnitedHealthcare membership. Despite headwinds from UHC's membership decline, OptumRx won 800 new customers through a strong selling season. The segment is differentiating itself through a 'transparency guarantee,' 100% rebate pass-through, and the removal of reauthorizations for 180 drugs, positioning it as a growth engine independent of the core insurance business.
UnitedHealth Group is realigning its corporate structure to better integrate technology and finance. The decision to move Optum Financial Services from OptumHealth to OptumInsight aims to combine revenue cycle solutions with payment capabilities. This creates a 'closed loop' approach to healthcare transactions, aiming to modernize the industry and unlock new value pools through real-time processing.
OptumHealth reported significant Q4 volatility, missing operating income guidance by a wide margin (guidance was 'just under $3 billion', actuals were closer to $2.3 billion before adjustments). Management attributed this to restructuring charges and elevated medical costs, but such a large miss this late in the year raises concerns about the predictability and stability of the business model.
The Medicare Advantage segment faces severe regulatory headwinds heading into 2027. Management noted that the CMS advance notice 'simply doesn't reflect the reality of medical utilization,' citing a 10% cost trend versus inadequate funding. This creates a risk of further benefit cuts or geographic exits in 2027, potentially disrupting the growth narrative.
Elevated medical cost trends are persisting across all business lines. Medicare trend is expected to be 10% in 2026, and commercial trend is approaching 11%. While pricing actions are catching up, the sustained high level of inflation suggests a prolonged period of margin pressure where pricing must constantly chase costs.
Total company membership is expected to contract significantly in 2026, with a decline of 2.3 to 2.8 million members. While framed as a strategic move to improve margins, sustained share loss in the Individual ACA market and Medicare Advantage could weaken the company's provider leverage and market positioning over the long term.
Management deflected specific questions regarding 2027 profitability and margins, stating it is 'too early to talk point estimates.' Given the structural changes occurring in 2026 (membership cuts, restructuring) and the known 2027 funding headwinds, this lack of visibility creates uncertainty for the medium-term earnings trajectory.
Overall: Management displayed a tone of disciplined resilience and renewed focus. While acknowledging the 'challenges' and 'volatility' of 2025, particularly within OptumHealth, executives were emphatic about the strength of the new strategic direction. There was a palpable shift from defensive explanations to proactive operational control, with leaders stressing 'execution' and 'accountability' as the primary themes for 2026.
Confidence: HIGH - Management provided specific guidance ranges for 2026 and detailed the mechanics of their turnaround strategy. Despite significant headwinds from Medicare funding cuts and elevated medical trends, they reaffirmed long-term growth targets (13-16%) and expressed strong conviction in their 'margin over membership' strategy.
Greater than $17.75 (growth of at least 8.6%)
Approximately $440 billion
88.8% plus or minus 50 basis points
12.8% plus or minus 50 basis points
At least $18 billion
Hedging & Uncertainty: Management utilized hedging language primarily regarding the external environment and 2027 specifics, while remaining definitive on internal operational plans. Terms like 'approximately,' 'range,' and 'expect' were used frequently for financial metrics. However, when discussing the strategic pivot, language was assertive ('We are driving greater operational disciplines'). Notably, there was significant hedging around the 2027 Medicare rates ('likelyhood to play out not dissimilar'), suggesting caution about the regulatory impact.
Our 2026 approach favored margin recovery and these membership trends are a result of these actions. - Timothy Noel, CEO of UnitedHealthcare
The advance notice published yesterday simply doesn't reflect the reality of medical utilization and cost trends. - Timothy Noel, CEO of UnitedHealthcare
We are clearly embarking on a new age of technology... We plan to be a leader in that movement. - Stephen Hemsley, Chairman and CEO
We have reoriented OptumHealth back towards our original purpose. - Krista Nelson, OptumHealth
The long term growth rate for this enterprise... has actually never been better. - Stephen Hemsley, Chairman and CEO
Analyst Sentiment: Analysts were highly focused on the sustainability of the Medicare Advantage margins given the 2027 rate cuts and the mechanics of the OptumHealth miss. There was skepticism about the trade-off between membership loss and margin recovery.
Management Responses: Management was well-prepared with specific data points to defend their pricing strategy. They deflected specific 2027 financial questions but stood firm on the logic of their 2026 reset, emphasizing that membership losses were within 'internal planning ranges.'
Analysts pressed for details on the 2027 Medicare Advance Notice, with management confirming it was 'disappointing' and would likely lead to further benefit reductions.
The volatility in OptumHealth was a major topic, with management explaining the Q4 miss as a result of necessary restructuring charges and network optimization.
Questions regarding the breakdown of commercial membership losses revealed that the ACA exchanges were the primary driver of the decline, with management confirming a move to positive margins in that segment.
UnitedHealth Group is executing a necessary and aggressive reset of its business model to prioritize profitability over volume. While the near-term headlines focus on significant membership declines (2.3M+ members) and the noise of OptumHealth restructuring, the financial core remains robust. The 2026 guidance for >8.6% EPS growth demonstrates strong pricing power and operational discipline. The strategic pivot to 'back to basics' value-based care, combined with a massive $1.5B AI investment drive, positions the company to emerge stronger in 2027 and beyond. The current valuation likely over-discounts the membership losses while under-appreciating the margin expansion potential and the durability of the Optum platform. Investors should look through the 2026 transition to the stabilized, higher-quality earnings profile emerging in 2027.
The 2027 Advance Notice from CMS does not reflect the reality of 10% medical cost trends, creating a 'profoundly negative' funding gap that will force benefit reductions and market exits.
Medical cost trends remain elevated across the board, with Medicare at 10% and Commercial approaching 11%, driven by utilization and provider fee schedule increases.
AI and automation are moving from experimental to essential, driving $1B in cost savings and enabling 'real time' processing of financial and clinical transactions.